Literature DB >> 19596773

Genomic analysis of an attenuated Chlamydia abortus live vaccine strain reveals defects in central metabolism and surface proteins.

L S Burall1, A Rodolakis, A Rekiki, G S A Myers, P M Bavoil.   

Abstract

Comparative genomic analysis of a wild-type strain of the ovine pathogen Chlamydia abortus and its nitrosoguanidine-induced, temperature-sensitive, virulence-attenuated live vaccine derivative identified 22 single nucleotide polymorphisms unique to the mutant, including nine nonsynonymous mutations, one leading to a truncation of pmpG, which encodes a polymorphic membrane protein, and two intergenic mutations potentially affecting promoter sequences. Other nonsynonymous mutations mapped to a pmpG pseudogene and to predicted coding sequences encoding a putative lipoprotein, a sigma-54-dependent response regulator, a PhoH-like protein, a putative export protein, two tRNA synthetases, and a putative serine hydroxymethyltransferase. One of the intergenic mutations putatively affects transcription of two divergent genes encoding pyruvate kinase and a putative SOS response nuclease, respectively. These observations suggest that the temperature-sensitive phenotype and associated virulence attenuation of the vaccine strain result from disrupted metabolic activity due to altered pyruvate kinase expression and/or alteration in the function of one or more membrane proteins, most notably PmpG and a putative lipoprotein.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19596773      PMCID: PMC2738009          DOI: 10.1128/IAI.00189-09

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  28 in total

1.  Genome sequence and identification of candidate vaccine antigens from the animal pathogen Dichelobacter nodosus.

Authors:  Garry S A Myers; Dane Parker; Keith Al-Hasani; Ruth M Kennan; Torsten Seemann; Qinghu Ren; Jonathan H Badger; Jeremy D Selengut; Robert T Deboy; Hervé Tettelin; John D Boyce; Victoria P McCarl; Xiaoyan Han; William C Nelson; Ramana Madupu; Yasmin Mohamoud; Tara Holley; Nadia Fedorova; Hoda Khouri; Steven P Bottomley; Richard J Whittington; Ben Adler; J Glenn Songer; Julian I Rood; Ian T Paulsen
Journal:  Nat Biotechnol       Date:  2007-04-29       Impact factor: 54.908

2.  Comparison of whole genome sequences of Chlamydia pneumoniae J138 from Japan and CWL029 from USA.

Authors:  M Shirai; H Hirakawa; M Kimoto; M Tabuchi; F Kishi; K Ouchi; T Shiba; K Ishii; M Hattori; S Kuhara; T Nakazawa
Journal:  Nucleic Acids Res       Date:  2000-06-15       Impact factor: 16.971

3.  Field studies on enzootic abortion of ewes in south east Scotland.

Authors:  K A Linklater; D A Dyson
Journal:  Vet Rec       Date:  1979-10-27       Impact factor: 2.695

4.  Computational analysis of the polymorphic membrane protein superfamily of Chlamydia trachomatis and Chlamydia pneumoniae.

Authors:  J Grimwood; R S Stephens
Journal:  Microb Comp Genomics       Date:  1999

5.  Vaccination with temperature-sensitive mutant of Chlamydia psittaci against enzootic abortion of ewes.

Authors:  A Rodolakis; F Bernard
Journal:  Vet Rec       Date:  1984-02-25       Impact factor: 2.695

6.  Differential expression of Pmp10 in cell culture infected with Chlamydia pneumoniae CWL029.

Authors:  A S Pedersen; G Christiansen; S Birkelund
Journal:  FEMS Microbiol Lett       Date:  2001-09-25       Impact factor: 2.742

7.  Response of ewes to temperature-sensitive mutants of Chlamydia psittaci (var ovis) obtained by NTG mutagenesis.

Authors:  A Rodolakis; A Souriau
Journal:  Ann Rech Vet       Date:  1983

8.  In vitro and in vivo properties of chemically induced temperature-sensitive mutants of Chlamydia psittaci var. ovis: screening in a murine model.

Authors:  A Rodolakis
Journal:  Infect Immun       Date:  1983-11       Impact factor: 3.441

9.  Purification and partial characterization of the major outer membrane protein of Chlamydia trachomatis.

Authors:  H D Caldwell; J Kromhout; J Schachter
Journal:  Infect Immun       Date:  1981-03       Impact factor: 3.441

10.  Intrastrain and interstrain genetic variation within a paralogous gene family in Chlamydia pneumoniae.

Authors:  Wasna Viratyosin; Lee Ann Campbell; Cho-Chou Kuo; Daniel D Rockey
Journal:  BMC Microbiol       Date:  2002-12-02       Impact factor: 3.605

View more
  6 in total

1.  Interrogating Genes That Mediate Chlamydia trachomatis Survival in Cell Culture Using Conditional Mutants and Recombination.

Authors:  Julie A Brothwell; Matthew K Muramatsu; Evelyn Toh; Daniel D Rockey; Timothy E Putman; Michael L Barta; P Scott Hefty; Robert J Suchland; David E Nelson
Journal:  J Bacteriol       Date:  2016-07-13       Impact factor: 3.490

2.  Chlamydia psittaci genetic variants differ in virulence by modulation of host immunity.

Authors:  Isao Miyairi; Jonathan D Laxton; Xiaofei Wang; Caroline A Obert; Venkat R R Arva Tatireddigari; Nico van Rooijen; Thomas P Hatch; Gerald I Byrne
Journal:  J Infect Dis       Date:  2011-08-15       Impact factor: 5.226

Review 3.  Unraveling the basic biology and clinical significance of the chlamydial plasmid.

Authors:  Daniel D Rockey
Journal:  J Exp Med       Date:  2011-10-24       Impact factor: 14.307

Review 4.  Advances and Obstacles in the Genetic Dissection of Chlamydial Virulence.

Authors:  Julie A Brothwell; Matthew K Muramatsu; Guangming Zhong; David E Nelson
Journal:  Curr Top Microbiol Immunol       Date:  2018       Impact factor: 4.737

5.  Efficacy of a prepared tissue culture-adapted vaccine against Chlamydia psittaci experimentally in mice.

Authors:  J El-Jakee; Mahmoud D El-Hariri; Mona A El-Shabrawy; Afaf A Khedr; Riham H Hedia; Eman A Khairy; E S Gaber; Eman Ragab
Journal:  Vet World       Date:  2020-11-28

6.  Genomic evidence that the live Chlamydia abortus vaccine strain 1B is not attenuated and has the potential to cause disease.

Authors:  David Longbottom; Michelle Sait; Morag Livingstone; Karine Laroucau; Konrad Sachse; Simon R Harris; Nicholas R Thomson; Helena M B Seth-Smith
Journal:  Vaccine       Date:  2018-06-14       Impact factor: 3.641

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.